Archive of
Previous IPAC Investigations (investigations older than 12 months)
This page includes reports of infection prevention and control (IPAC) investigations in Toronto (e.g., doctors’ offices, dental clinics, hospitals and personal service settings (PSSs) such as tattoo, aesthetic, and body piercing establishments, etc.) where an IPAC lapse has been identified.
An IPAC lapse is when proper IPAC practices were not followed and have resulted in a risk of transmission of infectious diseases to clients, attendees or staff. This can be through a potential exposure to blood, body fluids, secretions, excretions, mucous membranes, non-intact skin, contaminated equipment or soiled items.
IPAC Investigation Process
Toronto’s Medical Officer of Health is alerted about IPAC lapses as the result of investigation and surveillance, as well as through public complaints or referral from a provincial regulatory body. If a lapse is identified following an investigation, Toronto Public Health (TPH) will post the investigation summary on this page, as per the Ontario Public Health Standards’ Infection Prevention and Control Disclosure Protocol, 2022, or as current. Investigation summaries are posted by location (i.e., for sites that have multiple locations, reports will correspond with one site only).
Legislative Requirements
IPAC lapse investigations and postings are carried out in accordance with the provincial Health Protection & Promotion Act (HPPA), the Ontario Public Health Standards (OPHS) and the following protocols:
Timelines, Archiving, and Review of archived investigations (12 to 24 months old)
Investigation summaries are moved to the “Previous IPAC Investigations” page 12 months from the investigation completion date.
At 24 months from the investigation end date, they are removed from the website.
To request a copy of a report that is older than 24 months, please visit the Freedom of Information (FOI) request page.
The IPAC lapse investigations look at IPAC issues during a specific point-in-time. Investigation summaries are only posted when TPH identifies an IPAC lapse. This page doesn’t guarantee the absence of IPAC issues in premises that have or do not have summaries posted.
The summary reports represent what was found at the time of the investigation and TPHs recommendations, based on the provincial requirements.
Dr. Esther Park (Initial Report)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Dr. Esther Park
20 Edna Ave, Toronto |
Type of premise/facility: (E.g. clinic, personal services setting) |
Gynecology Clinic |
Date Board of Health became aware of IPAC lapse |
September 19, 2024 |
Date of Initial Report posting |
November 5, 2024 |
Date of Initial Report update(s) (if applicable) |
|
How the IPAC lapse was identified |
Patient’s complaint |
Summary Description of the IPAC Lapse |
- Inadequate reprocessing
- No reprocessing quality assurance records on site.
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
Yes, CPSO |
If yes, was the issue referred to the regulatory college? |
Yes |
Were any corrective measures recommended and/or implemented? |
Yes
- Re-processing steps and use of disinfectants reviewed and corrected.
- Owner replacing re-usable instruments with single-use devices (SUDs) where possible.
|
Please provide further details/steps |
Risk assessment consultation with PHO ongoing |
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
October 10, 2024, Dr. Park was directed to review and correct reprocessing procedure.
October 11, 2024, MIFU for disinfectants reviewed with Dr. Park. |
Initial Report Comments |
Details |
Any Additional Comments |
Reprocessing corrected as per MIFU and IPAC Best Practices |
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments |
|
Final Report |
Details |
Date of Final Report posting |
|
Date of any order(s) or directive(s) were issued to the owner/operator (if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Comments |
. |
If you have any further questions, please contact:
Danielle R. Steinman
Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control
Danielle.Steinman@toronto.ca
416-338-8400
Glam Forever Beaute (Initial Report)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Glam Forever Beaute
1237 Woodbine Avenue, BSMT, Toronto |
Type of premise/facility: (E.g. clinic, personal services setting) |
Personal Services Settings |
Date Board of Health became aware of IPAC lapse |
January 5, 2024 |
Date of Initial Report posting |
|
Date of Initial Report update(s) (if applicable) |
|
How the IPAC lapse was identified |
Complaint received January 5, 2024 |
Summary Description of the IPAC Lapse |
- Inadequate reprocessing of reusable nail tools between clients.
- Re-use of single-use items such as buffers. Re-useable items not maintained in a sanitary manner.
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
No |
If yes, was the issue referred to the regulatory college? |
No |
Were any corrective measures recommended and/or implemented? |
HPPA Section 13 Verbal Order on premises owner to:
- Reprocess all reusable nail tools
- Properly store clean and disinfected tools
- Discard all single-use items immediately after use
- Maintain premises in a sanitary manner
|
Please provide further details/steps |
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
January 5, 2024 |
Initial Report Comments |
Details |
Any Additional Comments |
On-site re-inspection to be conducted. |
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments |
|
Final Report |
Details |
Date of Final Report posting |
|
Date of any order(s) or directive(s) were issued to the owner/operator (if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Comments |
. |
If you have any further questions, please contact:
Cecilia Alterman
Manager, Control of Infectious Diseases/Infection Control
Cecilia.Alterman@toronto.ca
416-338-8400
Hopewell Medical Clinic and Walk-in (Initial & Final Reports)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Hopewell Medical Clinic and Walk-in (Dr. M. Rofail) |
Type of premise/facility: (e.g. clinic, personal services setting) |
Medical Clinic |
Date Board of Health became aware of IPAC lapse |
Feb 1, 2024 |
Date of Initial Report posting |
Feb 13, 2024 |
Date of Initial Report update(s) (if applicable) |
|
How the IPAC lapse was identified |
Complaint |
Summary description of the IPAC lapse |
- Incomplete reprocessing quality assurance.
- Inappropriate packaging of items to be sterilized.
- Inadequate labelling of sterilization packages.
- Inconsistent record keeping of the sterilizer’s physical parameters.
- No plumbed eyewash station on site.
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
Yes |
If yes, was the issue referred to the regulatory college? |
College of Physicians and Surgeons of Ontario |
Were any corrective measures recommended and/or implemented? |
Yes |
Please provide further details/steps |
- Stop use of the ‘the current sterilizer.’
- Affix a sign to the current sterilizer to say, “not to be used”, immediately until TPH has authorized you to resume providing service(s).
- Conduct pre-qualification of sterilizer with 3 consecutive Biological Indicators (BI), using a process challenge device (PCD), and notify TPH of the results prior to resuming use of the sterilizer for reprocessing any instruments.
- Use Single Use Devices in the interim until reprocessing issues are resolved.
- Do not use any multi-use instruments that require reprocessing until TPH has informed you, that you may resume use.
- Conduct a BI daily, in a PCD, for each day the sterilizer is in use.
- All items to be sterilized are packaged appropriately in an unlocked and open position without overlapping.
- Sterilization packages are to be labelled with:
- Date of sterilization
- Load number
- Reprocessing personnel’s initials
- Maintain logs of the sterilizer’s physical parameters and chemical indicators for every cycle and log BI results daily.
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
Verbal order issued on February 5, 2024 |
Initial Report Comments |
Details |
Any additional comments |
|
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments |
|
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
Final Report |
Details |
Date of Final Report posting: |
April 2, 2024 |
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
Facility in compliance with all TPH recommendations previously provided from Feb 2024 visit. |
Date all corrective measures were confirmed to have been completed |
April 2, 2024 |
Final Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
If you have any further questions, please contact:
Danielle R. Steinman
Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control
Danielle.Steinman@toronto.ca
416-338-8400
Stockyards Medical- Family Practice & Walk In Clinic (Initial & Interim Report)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Stockyards Medical- Family Practice & Walk In Clinic
1980 St Clair Ave W Unit 203, Toronto, ON M6N 4X9 |
Type of premise/facility: (e.g. clinic, personal services setting) |
Community Clinic |
Date Board of Health became aware of IPAC lapse |
June 25, 2024 |
Date of Initial Report posting |
Aug 15, 2024 |
Date of Initial Report update(s) (if applicable) |
|
How the IPAC lapse was identified |
On July 5, 2024, during IPAC inspection in response to a complaint, TPH staff observed a sterilizer not meeting the best practices associated with reprocessing. |
Summary description of the IPAC lapse |
- Blood collection tubes holders were disinfected with ILD and re-used on multiple clients.
- The on-site sterilizer had been used from April 2023 to March 2024 without physical, mechanical or biological verification and reprocessing records.
- Reprocessing room had no one-way flow to prevent cross contamination. Unrelated items were stored inside the re-processing room.
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
CPSO |
If yes, was the issue referred to the regulatory college? |
Yes |
Were any corrective measures recommended and/or implemented? |
Yes |
Please provide further details/steps |
- Blood collection tube holders replaced with SUD.
- Order Sec 13 HPPA was given to the Manager to immediately stop re-processing on site.
- Set up and follow verification processes for the autoclave, keep re-processing records as required.
- Create one way process flow in reprocessing room.
- Remove/relocate items not pertaining to reprocessing.
- May re-start use of the autoclave only after receiving an approval from TPH
- The Clinic conducted three consecutive BI on the autoclave as per TPH request. Passed.
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
Verbal Order Sec 13 HPPA issued on June 5, 2024
Recommendations Letter sent to the Clinic on July 29, 2024. |
Initial Report Comments |
Details |
Any additional comments |
The Clinic does not do re- processing on site currently. |
Interim Report |
Details |
Date of Interim Report posting: |
Sept 9, 2024 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
Re-inspection conducted on September 6, 2024 |
Brief description of corrective measures taken |
Clinic in compliance with requirements:
- Re-usable items replaced with SUDs
- The RITTER autoclave removed from the location.
|
Date all corrective measures were confirmed to have been completed |
Sept 6, 2024 |
Interim Report Comments |
Details |
Any additional comments |
No comments |
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
Final Report |
Details |
Date of Final Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Final Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
If you have any further questions, please contact:
Danielle R. Steinman
Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control
Danielle.Steinman@toronto.ca
416-338-8400
Universal Smiles Dental Centre (Initial Report)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Universal Smiles Dental Centre
204 Rouge Hills Dr
Toronto, ON M1C 2Z1 |
Type of premise/facility: (E.g. clinic, personal services setting) |
Mobile Dental Hygiene Clinic (bus) |
Date Board of Health became aware of IPAC lapse |
November 23, 2023 |
Date of Initial Report posting |
April 3, 2024 |
Date of Initial Report update(s) (if applicable) |
|
How the IPAC lapse was identified |
Self -reporting |
Summary description of the IPAC lapse |
- No hand hygiene sink available in clinical area (dental hygiene bus),
- Sterilizer:
- Not approved by Health Canada
- Inappropriate cycle use for wrapped instruments
- Quality assurance logbook did not reflect parameters for sterilization
- Portable dental unit used was not approved by Health Canada.
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
Yes |
If yes, was the issue referred to the regulatory college? |
College of Dental Hygienists of Ontario |
Were any corrective measures recommended and/or implemented? |
Operator voluntary stopped operating until appropriate equipment and IPAC processes can be obtained and organized. |
Please provide further details/steps |
- Ensure hand hygiene sink installed in the mobile dental clinic,
- Ensure use of a Health Canada approved healthcare devices and instruments (including but not limited to sterilizer and dental unit),
- Ensure Quality assurance logs are appropriately maintained,
- Complete Provincial IPAC training (eg. reprocessing)
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
Business no longer in operation. Operator will notify TPH prior to resuming mobile dental hygiene services. |
Initial Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
Final Report |
Details |
Date of Final Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Final Report Comments |
Details |
Any additional comments |
|
If you have any further questions, please contact:
Danielle R. Steinman
Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control
Danielle.Steinman@toronto.ca
416-338-8400
Victoria Medical Group (Initial & Interim Report)
Initial Report |
Details |
Premise/facility under investigation (name and address) |
Victoria Medical Group
1252 Lawrence Ave East, suite 201, Toronto ON |
Type of premise/facility: (e.g. clinic, personal services setting) |
Medical Clinic |
Date Board of Health became aware of IPAC lapse |
Jan 3, 2024 |
Date of Initial Report posting |
Jan 12, 2024 |
Date of Initial Report update(s) (if applicable) |
N/A |
How the IPAC lapse was identified |
Other |
Summary description of the IPAC lapse |
- Failure to manage sterile items in a manner to differentiate sterile from non-sterile items
- Inadequate sterilization process, including quality assurance and 1-way flow of processes
- Utilization of expired chemicals, sharps, and medication
- Failure to maintain a dedicated reprocessing room
- Failure to maintain hand hygiene items at point of use
- Reprocessing and re-use of single use devices
|
IPAC Lapse Investigation |
Results |
Did the IPAC lapse involve a member of a regulatory college? |
Yes |
If yes, was the issue referred to the regulatory college? |
Yes |
Were any corrective measures recommended and/or implemented? |
Yes |
Please provide further details/steps |
On Jan 8, 2024, the premise was verbally ordered under the authority of section 13(7) of the Health Protection and Promotion Act, 1990, as below:
- Stop use of ‘the current sterilizer’ Ritter M7 Speed Clave Sterilizer for reprocessing instruments, and use of any items that have been reprocessed in this current sterilizer, until Toronto Public Health (TPH) has authorized you to resume providing service(s).
- Stop providing healthcare services that require use of multi-use instruments and/or instruments that are/have been reprocessed using the current sterilizer immediately until TPH has authorized you to resume providing service(s).
- Remove all instruments from sterilizer packaging and hold instruments to be reprocessed in a dedicated area, until TPH has authorized you to resume reprocessing and reprocess all items according to Provincial Best Practices for Sterilization.
- Affix a sign to the current sterilizer to say “not to be used”, immediately until TPH has authorized you to resume providing service(s).
- Perform 3 consecutive biological indicator tests (inside a process challenge device) on the current sterilizer and report results to TPH.
- Obtain ABHR, liquid soap, and paper towel in order to perform hand hygiene before and after providing care to a patient, and other points according to Provincial Best Practices
- Review and remove any and all expired chemicals, products, medications, cleaners, sharps, etc., that are outside of their expiry dates
- Stop re-use and/or reprocessing of any instruments that are labelled and/or intended as Single Use Devices
- Ensure that the reprocessing room is dedicated to only reprocessing, and has a 1-way flow of device management
- Stop providing any and all healthcare procedure in the reprocessing room
- Deliver service(s) using acceptable infection prevention and control practices as detailed above as corrective action required
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
HPPA Sec 13. Verbal Order Jan 8, 2024 |
Initial Report Comments |
Details |
Any additional comments |
|
Interim Report |
Details |
Date of Interim Report posting: |
March 21, 2024 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
|
Brief description of corrective measures taken |
All requirements listed in the Sec 13 HPPA order are in compliance. |
Date all corrective measures were confirmed to have been completed |
February 2, 2024 |
Interim Report Comments |
Details |
Any additional comments |
N/A |
Interim Report |
Details |
Date of Interim Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were
confirmed to have been completed |
|
Interim Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
Final Report |
Details |
Date of Final Report posting: |
|
Date any order(s) or directive(s) were issued to the owner/operator
(if applicable) |
|
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
|
Final Report Comments |
Details |
Any additional comments (Do not include any personal information or personal health information) |
|
If you have any further questions, please contact:
Danielle R. Steinman
Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control
Danielle.Steinman@toronto.ca
416-338-8400
Questions
To submit an IPAC concern or complaint
Contact Toronto Public Health at 416-338-7600 or publichealth@toronto.ca.
You will hear back from the team within one business day.